Jeong-hee Jeong

Title: Innovations by Jeong-hee Jeong in Immunomodulatory Cell Therapy.

Introduction

Jeong-hee Jeong is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of immunology through his innovative research and patents. His work focuses on developing therapies that utilize mesenchymal stem cells to treat immune disorders.

Latest Patents

Jeong holds a patent for an invention titled "MTOR/STAT3 signal inhibitor-treated mesenchymal stem cell having immunomodulatory activity, and cell therapy composition comprising same, for preventing or treating immune disorders." This patent describes a mesenchymal stem cell that has been treated with rapamycin to enhance its immunomodulatory properties. The invention details a preparation method for these cells, which express specific cell surface factors and can effectively treat individuals with immune disorders.

Career Highlights

Jeong-hee Jeong is affiliated with the Catholic University of Korea Industry-Academic Cooperation Foundation. His research has led to advancements in cell therapy, particularly in the context of immune disorders. His innovative approach combines cellular biology with therapeutic applications, showcasing his expertise in the field.

Collaborations

Jeong has collaborated with notable colleagues, including Chul Woo Yang and Mi-La Cho. These collaborations have further enriched his research and contributed to the development of effective therapies.

Conclusion

Jeong-hee Jeong's work exemplifies the intersection of innovation and medical science. His contributions to immunomodulatory therapies highlight the potential of mesenchymal stem cells in treating immune disorders. His ongoing research continues to pave the way for advancements in this critical area of healthcare.